S

Sosei Group Corp
TSE:4565

Watchlist Manager
Sosei Group Corp
TSE:4565
Watchlist
Price: 1 033 JPY 1.08% Market Closed
Market Cap: 92.9B JPY
Have any thoughts about
Sosei Group Corp?
Write Note

Sosei Group Corp
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sosei Group Corp
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
S
Sosei Group Corp
TSE:4565
Total Liabilities & Equity
ÂĄ152.3B
CAGR 3-Years
20%
CAGR 5-Years
21%
CAGR 10-Years
26%
Takeda Pharmaceutical Co Ltd
TSE:4502
Total Liabilities & Equity
ÂĄ14.6T
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
12%
Daiichi Sankyo Co Ltd
TSE:4568
Total Liabilities & Equity
ÂĄ3.3T
CAGR 3-Years
16%
CAGR 5-Years
10%
CAGR 10-Years
6%
Otsuka Holdings Co Ltd
TSE:4578
Total Liabilities & Equity
ÂĄ3.6T
CAGR 3-Years
9%
CAGR 5-Years
7%
CAGR 10-Years
6%
Chugai Pharmaceutical Co Ltd
TSE:4519
Total Liabilities & Equity
ÂĄ1.9T
CAGR 3-Years
12%
CAGR 5-Years
13%
CAGR 10-Years
10%
Astellas Pharma Inc
TSE:4503
Total Liabilities & Equity
ÂĄ3.5T
CAGR 3-Years
15%
CAGR 5-Years
12%
CAGR 10-Years
7%
No Stocks Found

Sosei Group Corp
Glance View

Market Cap
92.9B JPY
Industry
Pharmaceuticals

Sosei Group Corp. engages in the discovery, design, and development of medicines targeting G protein-coupled receptors (GPCRs). The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 198 full-time employees. The company went IPO on 2004-07-29. The pharmaceutical business is engaged in the research, development and sales of medicines, the management of regenerative medical funds, the investment in bio venture companies related to regenerative medicine, the overseas development by licensing, the promotion of commercialization, the structural analysis of GPCR, the initial lead compound creation, the candidate search by proprietary StaR technology, as well as structural base of new drugs using GPCR related basic technology drug discovery, screening, promotion of antibody drug research and development.

Intrinsic Value
1 330.98 JPY
Undervaluation 22%
Intrinsic Value
Price
S

See Also

What is Sosei Group Corp's Total Liabilities & Equity?
Total Liabilities & Equity
152.3B JPY

Based on the financial report for Sep 30, 2024, Sosei Group Corp's Total Liabilities & Equity amounts to 152.3B JPY.

What is Sosei Group Corp's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
26%

Over the last year, the Total Liabilities & Equity growth was 2%. The average annual Total Liabilities & Equity growth rates for Sosei Group Corp have been 20% over the past three years , 21% over the past five years , and 26% over the past ten years .

Back to Top